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Background: Due to advances in surgical and medical care, survival has improved in patients with congenital heart disease (CHD). This has led to 
an increasing number of surviving patients with systemic to pulmonary shunt, who are at risk of developing pulmonary arterial hypertension (PAH). 
We aimed to determine the prevalence rate of CHD-PAH, which is currently not exactly known. Moreover we studied the impact of PAH on social life.
Methods: In this cross-sectional study we identified patients at risk from the Dutch CONCOR registry. Patients with right ventricular outflow tract 
obstruction or left sided cardiac valvular disease were excluded. Clinical characteristics were obtained from patient records. Systolic pulmonary 
arterial pressure (sPAP), calculated by means of transthoracic echocardiogram, was used to define PAH as possibly (sPAP > 37mmHg) or likely (sPAP 
> 50mmHg). We evaluated socioeconomic status in a subset of patients by means of a questionnaire.
Results: In total 5,759 (43%) of all 13,227 registered CHD patients were at risk of PAH. Preliminary results show a PAH prevalence of 13.5% with a 
mean age of 47 years. Eisenmenger syndrome was present in 27% of PAH patients and 39% had impaired right ventricular function (p<0.0001). Rate 
of unemployment was significantly higher in patients with PAH.
Conclusion: In this ongoing study we report a prevalence of PAH in adult CHD patients of 13.5% which is higher than the current estimates. 
Furthermore PAH is associated with a lower socioeconomic status.
CHD-PAH CHD without PAH
Female, % 63 57
Age, years mean 47 * 36
NYHA functional class, mean 2.0 * 1.1
Defect closed, % 59 69
Impaired right ventricular function, % 39 * 21
sPAP (mmHg), mean 58 * 26
High level of education, % 7.0 28
Currently employed, % 36 * 73
* p < 0.05
